In the absence of ischemia, OVA-containing scaffolds did not significantly increase the recruitment of antigen-specific CD4+ T cells to the OVA-containing scaffold and the adjacent upper leg muscles as compared with the blank scaffold at day 7 after scaffold implantation (fig. The gene discussed is CD4; the disease is ischemia.